Clinical Trial Update: Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intravenous elezanumab for safety and efficacy in adults with acute traumatic cervical spinal cord injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Elezanumab (elezanumab)

Snippet

Sponsor: AbbVie | Conditions: Spinal Cord Injury (SCI) | Phase 2 | Status: COMPLETED